KHC•November 12, 2026 at 12:17 PM UTCFood, Beverage & Tobacco

Kraft Heinz Bets on Novel Products Like Cheesy Ramen and High-Protein Jell-O to Revive Aging Brands

Read source article

What happened

Kraft Heinz is stepping up investments in new products, as reported by WSJ, with offerings such as cheesy ramen and high-protein Jell-O aimed at reinvigorating its portfolio. This move aligns with the company's previously announced $600 million reinvestment plan, which focuses on marketing, R&D, and product superiority, as detailed in the DeepValue master report. The report had rated KHC a WAIT at $22.90, citing volume-led declines (FY2025 volume/mix -4.1pp) and the need for proof that spending converts to units by Q3 2026. While the new product launches demonstrate execution on innovation, they do not yet provide evidence of volume stabilization or share gains beyond the 'Taste Elevation' categories. Investors remain focused on whether these innovations can drive measurable improvement in organic sales and volume/mix, with key checkpoints in H2 2026.

Implication

For investors, the news confirms that management is executing on the innovation component of the reinvestment plan, but the key risk remains whether these products can win in the aisle against private label and competitors. With the stock still below the master report's base case of $26, any positive volume data from new products could support a rerating, but the Berkshire overhang and prior impairments keep sentiment fragile. The master report's attractive entry was $21, and the stock traded near that level in early April 2026; if the news triggers a rally, investors should be cautious about chasing without volume evidence. The real test will be the Q3 2026 earnings release, where management must show that marketing and R&D intensity led to improved volume/mix and share gains beyond niche categories. Until then, the company's strong free cash flow ($3.7B in FY2025) provides a floor, but investors should wait for operational inflection before upgrading the thesis.

Thesis delta

The thesis remains unchanged: KHC is a WAIT because the reinvestment plan's success is unproven. The WSJ report on new products like cheesy ramen and high-protein Jell-O indicates the company is investing in innovation as promised, but it does not alter the core question of whether these products will resonate with consumers and drive volume growth. The delta is marginal, adding a datapoint on execution but not yet on outcomes.

Confidence

medium